Ivabradine and Darunavir Interaction

Drug interaction information between Ivabradine and Darunavir.

Ivabradine and Darunavir have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Ivabradine and Darunavir. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Ivabradine

HCN Channel Blocker

Drug B

Darunavir

HIV Protease Inhibitor

How They Interact

Darunavir prevents your body from clearing ivabradine, which causes the drug to build up to unsafe levels. This increase can lead to severe or life-threatening reactions.

FDA Label Information

Cardiac Disorders : ranolazine, ivabradine ↑ ranolazine ↑ ivabradine Co-administration is contraindicated due to potential for serious and/or life-threatening reactions.

Frequently Asked Questions

What SPL severity band is on file for Ivabradine + Darunavir?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Darunavir has 101 labeled pairs on file vs Ivabradine's 10. In the major band specifically: Ivabradine has 4 (also Itraconazole, Nirmatrelvir/Ritonavir, Voriconazole); Darunavir has 15 (also Lovastatin, Sildenafil, Lurasidone, Pimozide).

What mechanism field is on file for Ivabradine and Darunavir?

Darunavir prevents your body from clearing ivabradine, which causes the drug to build up to unsafe levels. This increase can lead to severe or life-threatening reactions.

Darunavir carries more major-labeled pairs than Ivabradine

SPL source-record counts only. This page's band is major · classes on file: Ivabradine (HCN Channel Blocker); Darunavir (HIV Protease Inhibitor).

Darunavir has 15 major-labeled pairs vs Ivabradine's 4.

Ivabradine

4 major · 2 moderate · 4 minor · 10 total

Darunavir

15 major · 16 moderate · 70 minor · 101 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.